Pharmaceutical packaging splits into three layers, and once you understand the split, most packaging discussions in pharma make a lot more sense. Each layer has its own job, its own materials, its own regulators. Mix them up and a batch can pass all three QA checks individually but still fail in the warehouse.
Primary packaging: the layer that touches the medicine
A blister cavity, a vial, an ampoule, a pre-filled syringe. Whatever directly contacts the drug. The material has to pass extractables and leachables testing under USP and Ph. Eur., which means the choice is regulatory, not aesthetic. Glass for sterile injectables. PVC, PVDC, ACLAR, or Alu-Alu for solid orals, depending on stability data. HDPE for OTC pills.
If the API is hygroscopic, primary packaging is where you live or die. Pick PVC for a moisture-sensitive drug and you'll watch your stability data crumble around month nine.
Secondary packaging: the carton, wallet, or kit
The layer the patient sees first. Folding cartons with a leaflet inside. Blister wallets with a calendar layout. Multi-component kits for clinical trials. This is where branding lives, but it's also where compliance lives: tamper-evidence, 2D Data Matrix code for FMD, Braille for the EU Directive 2004/27/EC, multi-language patient information.
Secondary packaging is the layer that decides whether the patient takes their dose on time. A wallet with a printed calendar can support adherence better than a generic carton. That single change is often worth more in trial outcomes than tweaking the API formulation.
Tertiary packaging: the bulk shipping layer
The cardboard case, the pallet, the temperature-controlled container. The patient never sees this. Its only job is to deliver a thousand secondary packs from the packaging site in Echt to a wholesaler in Frankfurt without anything breaking, leaking, or warming past 8°C.
Most sustainability conversations in pharma are tertiary conversations. Corrugated cardboard and shrink film add up to the largest emissions footprint per shipped unit, and that's also where the easiest swap-outs live (FSC paperboard, recycled corrugated, biodegradable wrap).
Where the layers fight each other
The classic launch problem: primary is fine, secondary is fine, but the tertiary fails its lane qualification because nobody tested the carton-in-pallet stability under summer conditions in Madrid. Six months of work, a pallet of returns, and a deviation report that takes a quarter to close.
The other classic: secondary doesn't fit the primary properly, and during transport the blisters rub against the carton wall, scratch the foil, and the tamper-evidence seal looks broken when it isn't. Pharmacist refuses to dispense.
How to spec the three layers right
Top-down, from the stability study outward. The primary material is dictated by the API. The secondary format is dictated by the patient (calendar, child-resistance, language) plus regulation (FMD, Braille). The tertiary configuration is dictated by lane qualification (route, temperature, transit time).
For the carton, wallet or kit around your primary pack, see secondary contract packaging.
We've spent more than a decade making the three layers fit for pharma. If you're scoping a new launch and want to map the layers from your stability data, send us the brief and we'll come back with the full configuration.
